Prevalence of quinolone resistance among extended-spectrum β -lactamase producing uropathogenic Klebsiella pneumoniae

Jundishapur Journal of Microbiology

Volumn 7, Issue 6, 2014, Pages

  Raei, Fereshteh ^a   Eftekhar, Fereshteh ^a   Feizabadi, Mohammad Mehdi ^b  

^a SHAHID BEHESHTI UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Klebsiella pneumoniae; Quinolone; Lactamase

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; NALIDIXIC ACID; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DISK DIFFUSION; ENZYME SYNTHESIS; KLEBSIELLA PNEUMONIAE; LABORATORY TEST; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPIC CONFIRMATORY TEST; PREVALENCE;

EID: 84902382025     PISSN: 20083645     EISSN: 20084161     Source Type: Journal    
DOI: 10.5812/jjm.10887     Document Type: Article

References (20)

1. Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev. 1998; 11(4): 589-603.
2. Dbaibo GS. Old and new targets of antibacterial therapy. J Med Liban. 2000; 48(4): 177-81.
3. Park Y, Kang HK, Bae IK, Kim J, Kim JS, Uh Y, et al. Prevalence of the extended-spectrum beta-lactamase and qnr genes in clinical isolates of Escherichia coli. Korean J Lab Med. 2009; 29(3): 218-23.
4. Kim MH, Lee HJ, Park KS, Suh JT. Molecular characteristics of extended spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae and the prevalence of qnr in Extended spectrum beta-lactamase isolates in a tertiary care hospital in Korea. Yonsei Med J. 2010; 51(5): 768-74.
5. Robicsek A, Jacoby GA, Hooper DC. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis. 2006; 6(10): 629-40.
6. Fuursted K, Schumacher H. Significance of low-level resistance to ciprofloxacin in Klebsiella pneumoniae and the effect of increased dosage of ciprofloxacin in vivo using the rat granuloma pouch model. J Antimicrob Chemother. 2002; 50(3): 421-4.
7. Tran JH, Jacoby GA. Mechanism of plasmid-mediated quinolone resistance. Proc Natl Acad Sci U S A. 2002; 99(8): 5638-42.
8. Martinez-Martinez L, Pascual A, Jacoby GA. Quinolone resistance from a transferable plasmid. Lancet. 1998; 351(9105): 797-9.
9. Karah N, Poirel L, Bengtsson S, Sundqvist M, Kahlmeter G, Nordmann P, et al. Plasmid-mediated quinolone resistance determinants qnr and aac(6')-Ib-cr in Escherichia coli and Klebsiella spp. from Norway and Sweden. Diagn Microbiol Infect Dis. 2010; 66(4): 425-31.
10. Pakzad I, Ghafourian S, Taherikalani M, Sadeghifard N, Abtahi H, Rahbar M, et al. qnr Prevalence in Extended Spectrum Betalactamases (ESBLs) and None-ESBLs Producing Escherichia coli Isolated from Urinary Tract Infections in Central of Iran. Iran J Basic Med Sci. 2011; 14(5): 458-64.
11. MacFaddin FJ. Biochemical tests for identification of medical bacteria. 3rd ed Philadelphia: Lippincott Williams & Wilkins; 2000.
12. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; Twenty first informational supplements. Clin Lab Stand Inst. 2011; 31(1).
13. Shahcheraghi F, Feizabadi MM. Drug resistance patterns of bacterial pathogens causing urinary tract infection at Torfeh Tehran Hospitals during 2002-2003. World Conference on Magic Bullets. Nurnberg. 2004.
14. Ode T, Saito R, Kumita W, Sato K, Okugawa S, Moriya K, et al. Analysis of plasmid-mediated multidrug resistance in Escherichia coli and Klebsiella oxytoca isolates from clinical specimens in Japan. Int J Antimicrob Agents. 2009; 34(4): 347-50.
15. Poirel L, Van De Loo M, Mammeri H, Nordmann P. Association of plasmid-mediated quinolone resistance with extendedspectrum beta-lactamase VEB-1. Antimicrob Agents Chemother. 2005; 49(7): 3091-4.
16. Lautenbach E, Strom BL, Bilker WB, Patel JB, Edelstein PH, Fishman NO. Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamaseproducing Escherichia coli and Klebsiella pneumoniae. Clin Infect Dis. 2001; 33(8): 1288-94.
17. Shahcheraghi F, Moezi H, Feizabadi MM. Distribution of TEM and SHV beta-lactamase genes among Klebsiella pneumoni ae strains isolated from patients in Tehran. Med Sci Monit. 2007; 13(11): BR247-50.
18. Tumbarello M, Spanu T, Sanguinetti M, Citton R, Montuori E, Leone F, et al. Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome. Antimicrob Agents Chemother. 2006; 50(2): 498-504.
19. Magesh H, Kamatchi C, Vaidyanathan R, Sumathi G. Identification of plasmid-mediated quinolone resistance genes qnrA1, qnrB1 and aac(6')-1b-cr in a multiple drug-resistant isolate of Klebsiella pneumoniae from Chennai. Indian J Med Microbiol. 2011; 29(3): 262-8.
20. Eftekhar F, Rastegar M, Golalipoor M, Mansoursamaei N. Detection of Extended Spectrum B-Lactamases in Urinary Isolates of Klebsiella pneumoniae in Relation to blaSHV, blaTEM and blaCTX-M gene carriage. Iran J Public Health. 2012; 41(3): 127-32.